Insurance company requirements place heavy administrative burden on physicians seeking to prescribe new cholesterol-lowering drugs

(University of Pennsylvania School of Medicine) A rare glimpse into the prior authorization requirements implemented by public and private insurance providers across the country has found substantial administrative burden for a new class of medications for patients with high cholesterol that places them at high risk for heart attack or stroke, according to new research.